Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Share-based Compensation (2021 - 2025)

Senti Biosciences has reported Share-based Compensation over the past 5 years, most recently at $1.4 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 135.54% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $5.7 million, up 225.13%, while the annual FY2025 figure was $5.7 million, 225.13% up from the prior year.
  • Share-based Compensation for Q4 2025 was $1.4 million at Senti Biosciences, down from $1.6 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $9.2 million in Q2 2022 and troughed at -$2.0 million in Q3 2023.
  • A 5-year average of $1.8 million and a median of $1.3 million in 2024 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 473.61% in 2022 and later tumbled 187.34% in 2023.
  • Year by year, Share-based Compensation stood at $735000.0 in 2021, then skyrocketed by 473.61% to $4.2 million in 2022, then crashed by 51.04% to $2.1 million in 2023, then tumbled by 70.69% to $605000.0 in 2024, then skyrocketed by 135.54% to $1.4 million in 2025.
  • Business Quant data shows Share-based Compensation for SNTI at $1.4 million in Q4 2025, $1.6 million in Q3 2025, and $1.5 million in Q2 2025.